ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/11/2025
Back to search
Official data from USPTO
PRIONICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
06/12/2025
Trademark type
Word
Nice classes
1, 5
Filing date
06/19/2001
Registration date
02/10/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/22/2024
Last transaction
06/12/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/19/2002
First use in commerce
06/19/2002
Drawing code
1
Owner type
25
Owner location
REINACH, CH
Examiner
KON, ELISSA
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
THERMO FISHER DIAGNOSTICS AG
PRIONICS AG
Representatives
Kenya Williams Thermo Fisher Scientific
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
REAGENTS FOR SCIENTIFIC AND INDUSTRIAL RESEARCH USE; TEST KITS COMPOSED OF DIAGNOSTIC REAGENTS FOR SCIENTIFIC USE; BIOCHEMICALSMONOCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC RESEARCH USE; RECOMBINANT PRION PROTEINS FOR IN VITRO SCIENTIFIC RESEARCH USE
Class 5
DIAGNOSTIC REAGENTS FOR CLINICAL MEDICAL AND VETERINARY LABORATORY USEFOR USE IN THE DIAGNOSIS OF NEUROLOGIC CONDITIONS AND FOR USE IN THE DIAGNOSIS OF DISEASES CAUSED BY PRIONS
Publications
History of USPTO decisions and trademark events.
39 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/22/2024
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/22/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/22/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/22/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
02/09/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/23/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/23/2014
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/18/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/18/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/18/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/17/2014
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
02/04/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
02/04/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/04/2009
PLGL
ASSIGNED TO PARALEGAL
06/24/2009
E815
TEAS SECTION 8 & 15 RECEIVED
06/18/2009
CORV
REVIEW OF CORRESPONDENCE COMPLETE
10/28/2008
PAPER RECEIVED
06/20/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/08/2003
DOCK
ASSIGNED TO EXAMINER
12/08/2003
DOCK
ASSIGNED TO EXAMINER
11/21/2003
CFIT
CASE FILE IN TICRS
11/19/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/06/2003
REIN
REINSTATED
10/17/2003
PAPER RECEIVED
09/11/2003
ABN6
ABANDONMENT - NO USE STATEMENT FILED
08/18/2003
IUAF
USE AMENDMENT FILED
02/12/2003
EISU
TEAS STATEMENT OF USE RECEIVED
02/12/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/15/2002
PUBO
PUBLISHED FOR OPPOSITION
07/23/2002
NPUB
NOTICE OF PUBLICATION
07/03/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2002
CNEA
EXAMINERS AMENDMENT MAILED
03/19/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2002
CNRT
NON-FINAL ACTION MAILED
08/30/2001
DOCK
ASSIGNED TO EXAMINER
08/29/2001
Continuous trademark protection
Get notified about every new filing that threatens PRIONICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.